Product Information

ATAZANAVIR SULFATE 200 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.1087 per EA under NDC 31722065460. Its NADAC has been published 92 times since Nov 20, 2024.

FDA first approved this application on Feb 2, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ATAZANAVIR SULFATE 200 MG CAP

Atazanavir
$1.1087per EA

Strength

200 mg/1

NDC

31722065460

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ATAZANAVIR SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212278

FDA Approved

2/2/2022

TE Code

AB

On Market Since

2/7/2022

Pharmacological Classes

Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
HIV Protease Inhibitors
Protease Inhibitor
UDP Glucuronosyltransferases Inhibitors
UGT1A1 Inhibitors

Price Statistics

The NADAC for ATAZANAVIR SULFATE 200 MG CAP has been published 92 times since Nov 20, 2024, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1087 per EA
All-time high$1.6664 (Oct 15, 2025)
All-time low$1.0536 (May 20, 2026)
52-week high$1.6664
52-week low$1.0536
Median price$1.6233
Average price$1.4002
Largest weekly change-22.4% (Dec 17, 2025)
Weeks tracked92
Tracking sinceNov 20, 2024

Price History

1W

-1.1%

1M

-1.1%

3M

+5.2%

6M

+1.0%

1Y

-31.8%

3Y

N/A

5Y

N/A

All

-31.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ATAZANAVIR SULFATE 200 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for ATAZANAVIR SULFATE 200 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $1.1087 per EA (NDC 31722065460), effective Aug 19, 2026.

How has the price of ATAZANAVIR SULFATE 200 MG CAP changed over time?

Over the history we have for it, the NADAC for ATAZANAVIR SULFATE 200 MG CAP has declined 31.7%. It has been tracked across 92 weekly CMS publications since Nov 20, 2024.

What are the highest and lowest recorded NADAC prices for ATAZANAVIR SULFATE 200 MG CAP?

Since Nov 20, 2024, the NADAC for ATAZANAVIR SULFATE 200 MG CAP has ranged from a low of $1.0536 (May 20, 2026) to a high of $1.6664 (Oct 15, 2025), with a median of $1.6233 per EA.

Are there cheaper alternatives to ATAZANAVIR SULFATE 200 MG CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATAZANAVIR SULFATE 200 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures ATAZANAVIR SULFATE 200 MG CAP?

ATAZANAVIR SULFATE 200 MG CAP (NDC 31722065460) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.